Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): Differential expression of microRNAs during EndMT

Keyphrases

• Acetylated Low-density Lipoprotein 7%
• Acetyltransferase p300 7%
• Activated Fibroblasts 7%
• Array Data 7%
• Bona Fide 7%
• Cardiac Endothelial Cells 14%
• Cardiac Fibrosis 14%
• Cardiovascular Disease 7%
• Catenin 7%
• Cell-derived 7%
• Collagen 7%
• Differential Expression 100%
• Dysregulated 7%
• Endothelial Cells 7%
• Endothelial-to-mesenchymal Transition (EndMT) 100%
• Epigenetic Regulators 7%
• Excessive Extracellular Matrix 7%
• Expression Level 7%
• Extracellular Matrix Protein 1 (ECM1) 14%
• Fibroblast-like 28%
• Fibroblasts 7%
• Fibrosis 7%
• Gene Expression 7%
• Growth Factor Signaling 7%
• Heart-kidney 7%
• Injured Tissue 7%
• Lipoprotein Uptake 7%
• MEK Inhibitor (MEKi) 7%
• MicroRNA 100%
• MicroRNA Array 7%
• MiR-125b 7%
• Morphological Changes 7%
• Myofibroblast 7%
• Pathological Conditions 7%
• PD98059 7%
• Pharmacologic Agents 7%
• Post-transcriptional Level 7%
• Pro-fibrotic Signaling 7%
• Protein Level 14%
• SB431542 7%
• Serine-threonine Kinase 7%
• Small Molecule Inhibitors 7%
• TGF-β Receptor 7%
• Transcript Level 7%
• Transforming Growth Factor Receptor 7%
• Transforming Growth Factor-β 35%
• α-smooth muscle Actin (α-SMA) 7%

Biochemistry, Genetics and Molecular Biology

• Acetyltransferase 16%
• Actin 16%
• Acyltransferase 16%
• Cancer Growth Factor 100%
• Catenin 16%
• Epigenetics 16%
• Extracellular Matrix Proteins 33%
• Fibroblast 100%
• Gene Expression 16%
• Growth Factor Receptor 16%
• Kinase 33%
• Low-Density Lipoprotein 16%
• MEK Inhibitor 16%
• MicroRNA 100%
• Morphology 16%
• Myofibroblast 16%
• P53 16%
• Phosphotransferase 33%
• Scleroprotein 33%
• Serine 16%
• Small Molecule 16%
• Threonine 16%

Immunology and Microbiology

• Actin 16%
• Cancer Growth Factor 100%
• Catenin 16%
• Extracellular Matrix 33%
• Fibroblast 100%
• Gene Expression 16%
• Matrix Protein 33%
• Morphology 16%
• Myofibroblast 16%
• P53 16%
• Smooth Muscle 16%